目的 探讨多维铁口服液联合维生素AD滴剂治疗婴幼儿缺铁性贫血的疗效。方法 将首次诊断缺铁性贫血的336例婴幼儿依家长意愿分为2个治疗组(A组和B组)与1个对照组,A组予多维铁口服液联合维生素AD滴剂治疗,B组予多维铁口服液联合维生素D滴剂治疗,对照组饮食调理并补充维生素AD,于治疗4周后(3天内)采末梢血行血细胞分析,比较三组患儿贫血治疗显效率、总有效率差异。结果 治疗4周后,A组显效率为71.70%,总有效率为97.17%;B组显效率为41.05%,总有效率为90.30%;对照组显效率为6.25%,总有效率为32.29%。A组贫血治疗显效率、总有效率高于B组和对照组,差异均有统计学意义(P<0.05)。结论 铁剂联合维生素A制剂可显著提高婴幼儿缺铁性贫血的治疗效果。

Objective To observe the curative effect of multivitamin iron oral solution combined with vitamin AD drops on the treatment of iron deficiency anemia in infants. Methods 336 cases of infants who was found with iron deficiency anemia for the first time were divided into two treatment groups (group A and group B) and one control group in accordance with their parents' will. Group A was treated with multivitamin iron oral solution combined with vitamin AD drops. Group B was treated with multivitamin iron oral solution combined with vitamin D drops. The control group was taken just dietary therapy combined with vitamin AD drops. All subjects were tested blood analysis after 4 weeks of treatment (within 3 days). The differences of the treatment excellence rates and the total effective rates were compared in the three groups. Results After 4 weeks of treatment, the excellence rate in group A was 71.70%. The total effective rate in group A was 97.17%. The excellence rate in group B was 41.05%. The total effective rate in group B was 90.30%. The excellence rate in control group was 6.25%. The total effective rate in control group was 32.29%. The differences of the treatment excellence rates and the total effective rates in group A were significantly higher than those in group B or in the control group. The differences were statistically significant (P<0.05). Conclusion Multivitamin iron combined with vitamin A can significantly improve the curative effect of the treatment of iron deficiency anemia in infants.

目的 探讨生血宁片对缺铁性贫血孕妇的治疗效果。方法 选取90个缺铁性贫血孕妇为研究对象,随机分为A、B、C三组,每组30人,从孕28周开始治疗,A组服用多糖铁复合物,B组口服生血宁片,C组采用营养科建议的补铁食疗菜谱,一直治疗至分娩前,治疗前后各检测血常规,血红蛋白(Hb)、红细胞比容(HCT)、红细胞平均体积(MCV)、红细胞平均血红蛋白浓度(MCHC)对比治疗效果。结果 服药前各组孕妇的血Hb、RBC、HCT、MCV、MCH无统计学差异,A、B组服药后Hb、RBC、HCT、MCV、MCH均高于服药前,且结果有统计学意义(P＜0.05),C组食疗前、后Hb、RBC、HCT、MCV、MCH无统计学差异,A、B、C三组之间Hb、RBC、HCT、MCV、MCH对比结果为,A、B组之间Hb、RBC、HCT、MCV、MCH差异无统计学意义(P＞0.05),但均高于C组,差异有统计学意义(P＜0.05)。结论 生血宁对孕晚期缺铁性贫血的孕妇有治疗作用,且效果与多糖铁复合物相当。

Objective To investigate the therapeutic effect of Shengxuening tablets on iron deficiency anemia in pregnant women. Methods Selected A total of 90 pregnant women with iron deficiency anemia as the research objects, randomly divided into A, B, C three groups. Each group of 30 people was treated since 28 weeks of pregnancy. Group A was treated with polysaccharide iron complex, group B with Shengxuening tablets, group C with the nutritionist recommended iron diet recipes. They have been treated till delivery. Before and after treatment, blood routine examination, the value of Hb,RBC,HCT,MCV,MCH had contrast treatment. Results There was no significant difference of serum Hb,RBC,HCT,MCV,MCH in the pregnant women before treatment. After treatment, Hb,RBC,HCT,MCV,MCH of group A, B were higher than before, and the results were statistically significant(P＜0.05). Before therapy of group C, there was no significant difference, in the three groups, results of Hb,RBC,HCT,MCV,MCH, there was no statistical difference between group A, B (P＞0.05), but both were higher than group C, the difference was statistically significant(P＜0.05). Conclusion There was therapeutic effect of Shengxuening in late pregnant women with iron deficiency anemia, and it is equal to the effect of Polysaccharide iron complex treatment.

       目的   探讨口服铁剂方法用于改善铁缺乏的男性机采血小板固定献血者铁营养状况效果，为采供血机构完善无偿献血者关爱策略提供数据支持。方法   选择2022年9月—2023年8月珠海市中心血站男性血小板固定献血者进行铁蛋白（FER）检测。以FER＜30 ng/mL为铁缺乏的判定标准。将49名铁缺乏的男性机采血小板固定献血者随机分成干预组、对照组，分别进行口服铁剂干预，比较两组干预前后血红蛋白（Hb）、血清铁（SI）、FER的浓度变化情况。结果   共检测205名男性机采固定献血者，其中49名FER＜30 ng/mL（铁缺乏组），占23.90%，其Hb、SI、FER均值低于FER≥30 ng/mL男性机采固定献血者（正常组）。49名铁缺乏的机采固定献血者口服铁剂干预后：干预组SI、FER浓度分别为（15.97±5.14）μmol/L、（30.55±14.42）ng/mL，高于对照组［（11.49±4.02）μmol/L、（12.77±5.86）ng/mL）］，其差异有统计学意义（t=3.466，P＜0.001；t=5.493，P＜0.001）。干预组Hb为（143.42±10.85）g/L，高于对照组的（140.88±12.97）g/L，但差异无统计学意义（t=-0.726，P=0.471）。结论   针对铁蛋白低值的机采男性固定献血者，采取口服铁剂方法可以有效改善其铁缺乏状况。

       Objective  To explore the effect of oral iron  supplements on improving iron  deficiency in male  regular plateletpheresis donors．Methods  Male regular plateletpheresis donors from Zhuhai Blood Central Station were selected for ferritin（FER）detection．Using FER＜30 ng/mL as the criterion for determining iron deficiency，49 donors were selected as the study subjects and divided into intervention group and control group，and the changes in hemoglobin（Hb），serum iron（SI），andFER concentrations were compared．Results  A total of 205 male regular plateletpheresis donors underwent FER detection，of which 49 donors had FER under 30 ng/mL（iron deficiency group），accounting for 23.90%．The mean Hb，SI，and FER levels in the iron deficiency group were significantly lower than those with FER≥30 ng/mL．After oral iron intervention，the SI and FER levels in the intervention group（［15.97±5.14］ μmol/L，［30.55±14.42］ ng/mL）were significantly higher than those in the control group（［11.49±4.02］ μmol/L，［12.77±5.86］ ng/mL），and the difference were statistically significant（t=3.466，P＜0.001；t=5.493，P=0.000）．The Hb values of the intervention group and the control group were（143.42±10.85）g/L and（140.88±12.97）g/L，respectively，with no statistically significant difference between the groups（t=-0.726，P=0.471）．Conclusions  Oral iron supplementation can effectively improve iron deficiency in male regular plateletpheresis donors．